Inactive Instrument
BELM PHAR Stock Nasdaq
Stocks
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -1.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 2024-02-22 |
Richard Fair
CEO | Chief Executive Officer | 57 | 2017-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.76% | -12.95% | - | - | 822K | |
| -2.37% | -4.92% | +44.84% | +65.82% | 55.2B | |
| +2.83% | +0.48% | +28.18% | +82.59% | 55.6B | |
| +0.54% | +1.22% | -16.62% | -13.47% | 23.51B | |
| -0.97% | -3.30% | -1.79% | +383.00% | 22.35B | |
| -4.01% | -3.67% | +13.17% | -14.29% | 20.6B | |
| -1.63% | -3.49% | +25.56% | -34.07% | 17.45B | |
| -3.34% | -7.77% | +23.78% | +536.66% | 15.16B | |
| -2.09% | +0.64% | +49.78% | +178.74% | 13.91B | |
| -3.14% | -8.47% | +165.37% | +292.18% | 13.74B | |
| Average | -1.59% | -1.27% | +36.92% | +164.13% | 26.39B | |
| Weighted average by Cap. | -0.89% | -0.52% | +32.22% | +127.23% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.45M 5.09M 4.67M 8.74M 594M 8.95M 60.3M 23.58M 294M 23.28M 22.77M 1.02B | 1.5M 1.32M 1.23M 1.13M 2.11M 144M 2.17M 14.59M 5.71M 71.1M 5.63M 5.51M 246M |
| Net income | -9.7M -8.53M -7.96M -7.31M -13.67M -930M -14.01M -94.39M -36.91M -460M -36.44M -35.65M -1.59B | -24.97M -21.94M -20.48M -18.8M -35.19M -2.39B -36.06M -243M -94.99M -1.18B -93.76M -91.73M -4.09B |
| Net Debt | - | - |
Employees
-
